Screening Scientist
Contact information
Research groups
Charline Giroud
Screening Scientist
She worked at the Department of Paediatric Infectious Diseases at the School of Medicine of Emory University of Atlanta, USA (2013) as a postdoctoral fellow. Using high throughput screening strategy combined to cell-based assay development, she discovered and characterized new HIV-1 and Ebola virus entry inhibitors for HIV-1 and Ebola virus entry. She started in the assay development and screening team in May 2017.
Recent publications
-
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function
Journal article
Fagan V. et al, (2019), Journal of Medicinal Chemistry
-
Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9.
Journal article
Christott T. et al, (2018), SLAS Discov
-
Development of a YEATS-domain chemical probe
Conference paper
Moustakim M. et al, (2018), ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 256
-
Screening and Functional Profiling of Small-Molecule HIV-1 Entry and Fusion Inhibitors
Journal article
GIROUD None. et al, (2017), ASSAY and Drug Development Technologies, 15, 53 - 63
-
P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
Journal article
Giroud C. et al, (2015), J Virol, 89, 9368 - 9382